Effects of inhibition of prostaglandin synthesis on fetal development, oxygenation, and the fetal circulation.
D000818:Animals; D001775:Blood Circulation; D004373:Ductus Arteriosus / Q000187:drug effects / Q000502:physiology*; D005260:Female; D005312:Fetal Blood / Q000378:metabolism; D005333:Fetus / Q000502:physiology*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology; D007213:Indomethacin / Q000009:adverse effects; D007223:Infant; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D010100:Oxygen / Q000097:blood; D010210:Papillary Muscles / Q000166:cytology; D011247:Pregnancy; D011453:Prostaglandins / Q000096:biosynthesis / Q000502:physiology*; D011652:Pulmonary Circulation / Q000187:drug effects; D012459:Salicylates / Q000009:adverse effects; D013045:Species Specificity; D014261:Tricuspid Valve; D014655:Vascular Resistance
D011453:Prostaglandins; D012459:Salicylates; D010100:Oxygen; D007213:Indomethacin